The randomized PICSO-AMI-I trial: pressure-controlled intermittent coronary sinus occlusion in AMI

by michaelg October 27, 2023

Video by PCR via YouTube
Go to Source
The randomized PICSO-AMI-I trial: pressure-controlled intermittent coronary sinus occlusion in AMI

Aaysha Cader interviews Giovanni Luigi De Maria about the results of the PICSO-AMI-I Trial which he presented during the TCT Congress 2023 in San Francisco.

Results of this first multicenter, prospective randomized trial of pressure controlled intermittent coronary sinus occlusion (PiCSO) therapy used in conjunction with primary percutaneous coronary intervention (pPCI) indicated that it did not reduce myocardial infarct size in patients with anterior ST-segment elevation myocardial infarction (STEMI).

Read more news from #TCT2023 here:
https://www.pcronline.com/News/Whats-new-on-PCRonline/2023/TCT/PCRonline-at-TCT-2023

Go to Source

EARTH-STEMI: Complete revascularisation benefits in… by Michaelg
SWISS-APERO: One-year outcomes after Amulet or… by Michaelg
T-PASS: Less than 1-month DAPT followed by… by Michaelg
DANGER-shock: Percutaneous transvalvular micro-axial… by Michaelg
TRISCEND II trial: TTVR vs. optimal medical therapy… by Michaelg
CLASP II D: A randomized comparison of TEER devices… by Michaelg

# education # innovation # innovative

The randomized PICSO-AMI-I trial: pressure-controlled intermittent coronary sinus occlusion in AMI

Related Posts: